<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Hedgehog (Hh) signaling is frequently activated in human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, including <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Most <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancers</z:e> are diagnosed in the advanced stages, therefore, identifying the very alterations that drive esophageal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> may help designing novel strategies to diagnose and treat the disease </plain></SENT>
<SENT sid="2" pm="."><plain>Analysis of Hh signaling in <z:e sem="disease" ids="C0940937" disease_type="Neoplastic Process" abbrv="">precancerous lesions</z:e> is a critical first step in determining the significance of this pathway for <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Here we report our data on Hh target gene expression in 174 human esophageal specimens [28 esophageal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> (EAC), 19 <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, 103 cases of esophageal <z:hpo ids='HP_0002860'>squamous cell carcinoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e>), and 24 of squamous dysplastic lesions], and in two rat models of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We found that 96% of human EAC express Hh target genes </plain></SENT>
<SENT sid="5" pm="."><plain>We showed that PTCH1 expression is the most reliable biomarker </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast to EAC, only 38% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e> express Hh target genes </plain></SENT>
<SENT sid="7" pm="."><plain>We found activation of Hh signaling in <z:e sem="disease" ids="C0940937" disease_type="Neoplastic Process" abbrv="">precancerous lesions</z:e> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCCs</z:e> and EACs in different degrees (21% and 58% respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>Expression of Hh target genes is frequently detected in severe squamous <z:mpath ids='MPATH_589'>dysplasia</z:mpath>/ <z:mp ids='MP_0002038'>carcinoma</z:mp> in situ (p=0.04) and <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (p=0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>Unlike EAC, sonic hedgehog (Shh) expression was rare in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCCs</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Consistent with the human specimen data, we found a high percentage of Hh signaling activation in <z:e sem="disease" ids="C0940937" disease_type="Neoplastic Process" abbrv="">precancerous lesions</z:e> in rat models </plain></SENT>
<SENT sid="11" pm="."><plain>These data indicate that Hh signaling activation is an early molecular event in the development of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, particularly EAC </plain></SENT>
</text></document>